Vice Chair for Research and Professor of Psychiatry, Department of Psychiatry, Columbia University
Director of Psychiatric Research, New York State Psychiatric Institute
Director of the Center for OCD and Related Disorders, New York State Psychiatric Institute
Dr. Simpson's research program translates science into new treatments for people with anxiety and related disorders, including obsessive-compulsive disorder (OCD). Because of her expertise, she was asked by the American Psychiatric Association to help develop their treatment guidelines for OCD and advised the American Psychiatric Association and the World Health Organization on the classification of Obsessive-Compulsive and Related Disorders.
Dr. Simpson is an ADAA board member and has been a member of ADAA since 2003.
Why I am an ADAA member
Because ADAA is the only organization that brings together leaders across the spectrum in the field of anxiety.
What do I value about ADAA's mission and how does my work fit into ADAA's mission?
I’ve dedicated my research career to advancing our understanding of and developing new treatments for patients with anxiety and OCD, and I care deeply that individuals with these disorders can access the latest treatments and live fulfilling lives. Thus, ADAA’s mission is my mission.
What do I think is the most exciting/interesting thing about what is currently happening in my lab or workplace?
Advances in our understanding of brain function are generating new ideas for what causes anxiety and OCD as well as novel targets for treatment development. I am very excited to use this science to help to transform clinical care.